Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

French Campaign To Boost Generics Gets Thumbs Up From European Industry Body

Executive Summary

The French health ministry is hoping a new campaign aimed at increasing the use of generics and dispelling any remaining doubts about their quality among the public will bring cost savings.

You may also be interested in...



France 2017: More Price Cuts, Rebates, Generics and Biosimilars, And A New Innovation Fund

The French pharmaceutical industry has reacted angrily to some of the provisions in the 2017 social security financing bill, arguing that the measures are inappropriate and that the government is taking a purely financial approach to addressing the costs of healthcare products, rather than taking wider public health considerations into account.

French unveil plan to save €350m through greater use of generics

The French government has unveiled plans to boost the prescribing and dispensing of generic medicines, with a view to making an additional €350m in savings over the next three years. Most of the measures are aimed at healthcare professionals and the public, although the authorities have called on pharmaceutical firms to help by printing the INN more prominently on product packs.

EU Prepares Ground For Deployment Of COVID-19 Vaccines

With the number of COVID-19 cases continuing to rise across Europe, the European Commission executive has published a set of actions to be taken at EU and national level to ensure future vaccines are allocated fairly, targeted at priority populations, and labeled in a way that increases production capacity, reduces transport costs and improves distribution.

Topics

UsernamePublicRestriction

Register

GB150348

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel